1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow DiGeorge Anomaly: new trials by email Literature Review of DiGeorge Anomaly trials Research Report on DiGeorge Anomaly
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Serum-Free Thymus Transplantation in DiGeorge Anomaly Serum Free Thymus Transplantation with Immunosuppression, Serum Free Thymus Transplantation without immunosuppression - DiGeorge Anomaly | Phase 1 | Terminated | Sumitomo Pharma Switzerland GmbH | 2 | 2008-04-01 | 2022-04-01 |
DiGeorge Syndrome (1) · Immunologic Deficiency Syndromes (1) · Thymic aplasia (1)
22q11 Deletion Syndrome (1) · Abnormalities, Multiple (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Craniofacial Abnormalities (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Hemic and Lymphatic Diseases (1) · Hypoparathyroidism (1) · Immune System Diseases (1)
Sumitomo Pharma Switzerland GmbH (1)
M. Louise Markert, M.D., Ph.D (1)
K12HD043494 (1), R01AI047040 (1), R01AI054843 (1)